Joycelyn Schindler, MD
Obstetrics & Gynecology · Little River, SCNPI 1750540118
Payments from drug & device makers
Across 211 payments — averaging $23.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Astellas Pharma US Inc$718
- Optumhealth Care Solutions, LLC$573
- Sumitomo Pharma America, Inc.$248
- Myovant Sciences Inc.$245
- Pfizer$161
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,44791%
- Education$4369%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $1,181 |
| Astellas Pharma US Inc | 22 | $718 |
| Optumhealth Care Solutions, LLC | 24 | $573 |
| Sumitomo Pharma America, Inc. | 9 | $248 |
| Myovant Sciences Inc. | 9 | $245 |
| Pfizer | 10 | $161 |
| Shield Therapeutics Inc | 9 | $141 |
| Hologic Sales And Service, LLC | 6 | $130 |
| Amgen | 2 | $127 |
| Daiichi Sankyo Inc. | 6 | $127 |
| Lilly USA, LLC | 3 | $127 |
| Aspira Women's Health Inc | 2 | $113 |
| Intuitive Surgical | 3 | $109 |
| Avion Pharmaceuticals | 5 | $80 |
| Organon | 5 | $79 |
| Mayne Pharma Commercial LLC | 3 | $67 |
| Millicent US Inc | 3 | $59 |
| Evofem Biosciences, Inc. | 4 | $57 |
| Scynexis, Inc. | 2 | $47 |
| Pacira Pharmaceuticals Incorporated | 2 | $46 |
| Exeltis, USA Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Merck | 3 | $40 |
| Novo Nordisk | 2 | $34 |
| Urovant Sciences Inc | 2 | $33 |
| Convatec Inc. | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $30 |
| Therapeuticsmd, Inc. | 2 | $29 |
| Roche Diagnostics Corporation | 1 | $25 |
| Mylan Pharmaceuticals Inc. | 1 | $24 |
| Lupin Inc. | 2 | $23 |
| Medicem Inc. | 1 | $19 |
| Innovation Technologies Inc | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Virtus Pharmaceuticals LLC | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Conmed Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVIFY HEALTH CARE TEAM PORTAL 001$263
- EITAN MEDICAL$263
- Orilissa$107
- OVA1$103
- Prolia$103
How this compares
$4,883 in reported general payments places this provider in the 85th percentile of 673 obstetrics & gynecology providers in South Carolina.
See all obstetrics & gynecology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 37 | $38,131 |
| OzempicSemaglutide | 24 | $27,317 |
| GemtesaVibegron | 19 | $15,391 |
| MyrbetriqMirabegron | 17 | $13,931 |
| PremarinEstrogens, Conjugated | 29 | $12,850 |
| PremproEstrogen,con/M-Progest Acet | 14 | $9,267 |
| Estradiol | 229 | $8,312 |
| Estradiol (Once Weekly)Estradiol | 26 | $2,810 |
| ValacyclovirValacyclovir Hcl | 69 | $2,513 |
| Estradiol (Twice Weekly)Estradiol | 23 | $2,187 |
| YuvafemEstradiol | 11 | $2,106 |
| Clobetasol Propionate | 92 | $1,925 |
| Acyclovir | 12 | $725 |
| Fluconazole | 70 | $538 |
| Medroxyprogesterone Acetate | 33 | $515 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $127 | $38,13137 claims |
| Novo NordiskOzempic | $34 | $27,31724 claims |
| PfizerPremarin, Prempro | $161 | $22,11843 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $248 | $15,39119 claims |
| Astellas Pharma US IncMyrbetriq | $718 | $13,93117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 673 obstetrics & gynecology providers in South Carolina.
Other obstetrics & gynecology in Little River
- Christopher JenningsAnderson$1.3M
- George HelmrichGreenville$1.2M
- Meghan HillColumbia$795K
- Patricia ThompsonBeaufort$649K
- Ronnie GivensSummerville$640K
- Helena KirkpatrickMyrtle Beach$527K
- Heather SchwartzbergSummerville$320K
- David GodwinGreenville$261K
- William ColemanGreenville$242K
- Melvin SeidMauldin$235K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.